Reckitt Benckiser Group plc (LON:RKT – Get Free Report) has earned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is GBX 6,178.86.
Several brokerages recently issued reports on RKT. Royal Bank Of Canada reiterated a “sector perform” rating and set a GBX 6,200 price target on shares of Reckitt Benckiser Group in a research report on Wednesday, July 29th. Jefferies Financial Group restated a “buy” rating and issued a GBX 5,900 price target on shares of Reckitt Benckiser Group in a report on Wednesday, July 29th. Berenberg Bank increased their price target on Reckitt Benckiser Group from GBX 5,179 to GBX 5,352 and gave the company a “hold” rating in a research report on Wednesday, August 5th. JPMorgan Chase & Co. lifted their target price on Reckitt Benckiser Group from GBX 5,800 to GBX 6,500 and gave the stock an “overweight” rating in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a GBX 5,400 price objective on shares of Reckitt Benckiser Group in a report on Thursday, July 30th.
Read Our Latest Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Performance
Reckitt Benckiser Group (LON:RKT – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported GBX 101.40 earnings per share for the quarter. Reckitt Benckiser Group had a return on equity of 42.87% and a net margin of 21.09%. Sell-side analysts forecast that Reckitt Benckiser Group will post 331.2110727 EPS for the current year.
Insider Transactions at Reckitt Benckiser Group
In other Reckitt Benckiser Group news, insider Shannon Eisenhardt acquired 432 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was acquired at an average price of £432 per share, for a total transaction of £186,624. Also, insider Deepak Nath bought 257 shares of the firm’s stock in a transaction on Tuesday, June 23rd. The shares were purchased at an average cost of GBX 4,650 per share, with a total value of £11,950.50. Insiders have purchased a total of 1,032 shares of company stock valued at $21,636,131 over the last quarter. 0.45% of the stock is currently owned by insiders.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
